larotrectinib sulfate

Italy

Drugs containing this active substance

  • VITRAKVI

    It is used in adults, adolescents, and children to treat solid tumors (cancer) in various parts of the body caused by an NTRK gene alteration, when the tumor is at an advanced stage, widespread, or cannot be surgically treated without serious complications, and no other satisfactory therapeutic options exist.

    Form: capsules, hard gelatin

    Active substance Dosage
    larotrectinib sulfate -

    ATC: L01EX12

    Manufacturer: BAYER AG